1. Home
  2. SPRC vs VTAK Comparison

SPRC vs VTAK Comparison

Compare SPRC & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • VTAK
  • Stock Information
  • Founded
  • SPRC 2004
  • VTAK 2002
  • Country
  • SPRC Israel
  • VTAK United States
  • Employees
  • SPRC N/A
  • VTAK N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • VTAK Medical/Dental Instruments
  • Sector
  • SPRC Health Care
  • VTAK Health Care
  • Exchange
  • SPRC Nasdaq
  • VTAK Nasdaq
  • Market Cap
  • SPRC 3.4M
  • VTAK 3.1M
  • IPO Year
  • SPRC N/A
  • VTAK 2018
  • Fundamental
  • Price
  • SPRC $0.31
  • VTAK $0.21
  • Analyst Decision
  • SPRC
  • VTAK
  • Analyst Count
  • SPRC 0
  • VTAK 0
  • Target Price
  • SPRC N/A
  • VTAK N/A
  • AVG Volume (30 Days)
  • SPRC 302.0K
  • VTAK 1.5M
  • Earning Date
  • SPRC 02-15-2025
  • VTAK 06-17-2025
  • Dividend Yield
  • SPRC N/A
  • VTAK N/A
  • EPS Growth
  • SPRC N/A
  • VTAK N/A
  • EPS
  • SPRC N/A
  • VTAK N/A
  • Revenue
  • SPRC $1,306,000.00
  • VTAK $481,000.00
  • Revenue This Year
  • SPRC N/A
  • VTAK $822.86
  • Revenue Next Year
  • SPRC N/A
  • VTAK $168.42
  • P/E Ratio
  • SPRC N/A
  • VTAK N/A
  • Revenue Growth
  • SPRC N/A
  • VTAK 9.57
  • 52 Week Low
  • SPRC $0.20
  • VTAK $0.16
  • 52 Week High
  • SPRC $1.79
  • VTAK $8.40
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 50.15
  • VTAK 40.89
  • Support Level
  • SPRC $0.30
  • VTAK $0.17
  • Resistance Level
  • SPRC $0.33
  • VTAK $0.21
  • Average True Range (ATR)
  • SPRC 0.02
  • VTAK 0.03
  • MACD
  • SPRC -0.00
  • VTAK -0.00
  • Stochastic Oscillator
  • SPRC 58.82
  • VTAK 32.31

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: